Searched for
ANTI MALARIA DRUG
For both the compulsive trader and careful investor: 25 stocks to watch if risk appetite returns; some with upside potential, some not- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 29%
- Pakistan health authorities seek government permission to import mosquito nets from India after malaria cases surge due to floods: report
- Pakistan bans export of anti-malaria drugs amid spike in coronavirus casesThe ban, which has been imposed with immediate effect, will remain till the National Coordination Comm-ittee (NCC) on COVID-19 deems necess...11 Apr, 2020, 03.39 PM IST
- After Donald Trump's Hydroxychloroquine clamour Bengal planters hope for surge in quinine demandUS President Donald Trump's strong advocacy of Hydroxychloroquine for treating COVID-19 patients has rekindled hopes of cinchona planters o...10 Apr, 2020, 01.02 PM IST
- Gujarat companies to export hydroxychloroquine to US: Vijay RupaniHydroxychloroquine is an old and inexpensive drug used to treat malaria, the export of which was banned by India last month amid views that...08 Apr, 2020, 09.56 AM IST
- India partially eases export curbs on Hydroxychloroquine, the anti-malaria drug Donald Trump wantsThe Indian government had earlier put a hold on exports of hydroxychloroquine.07 Apr, 2020, 03.50 PM IST
- Serious malaria cases cured by plant therapy in AfricaBengaluru, April 27 (IANS) In a stunningly successful trial, scientists report they cured 18 critically-ill patients suffering from drug-re...27 Apr, 2017, 12.10 PM IST
- Effective malaria treatment a step closerThe discovery could potentially make malaria treatment significantly more effective for the 3.2 billion people at risk.18 Apr, 2016, 04.09 PM IST
- Australian researchers find new drug to tackle malariaAustralian researchers said that a new drug that stops the malaria parasite from using vitamin B1 to multiply is now plausible.22 Jul, 2013, 10.41 AM IST
- India develops a synthetic anti-malaria drug as an alternative ArtemisininIndia has developed a powerful new malaria drug - an alternative to the global drug of choice Artemisinin - that promises to be a major boo...24 Apr, 2012, 09.27 AM IST
- Ranbaxy to launch India's first indigenous malaria drug at one-third the cost of current therapiesRanbaxy Laboratories will launch the country’s first indigenously developed new medicine, a malaria drug, at one-third the cost of the curr...14 Apr, 2012, 12.47 AM IST
- Drug-resistant malaria may spread, India warnedA new research has warned that drug-resistant malaria parasites on the border of Thailand & Myanmar may spread to India.06 Apr, 2012, 07.10 PM IST
- Ranbaxy gets nod for first drug developed by Indian pharma coThe proposed launch could provide a boost to Ranbaxy’s revenues as this combination drug will be cheaper and easier to consume, compared to...01 Nov, 2011, 04.17 PM IST
- Ranbaxy starts phase III study of anti-malaria drugRanbaxy Laboratories, India's largest drugmaker by sales, on Monday announced that its new anti-malarial combination drug is now undergoing...04 May, 2009, 03.10 PM IST
- Ranbaxy launches clinical trials for anti-malaria drugPharma firm Ranbaxy Laboratories on Monday said it has launched clinical trials for its anti-malaria drug Arterolanc maleate Piperaquine ph...04 May, 2009, 02.52 PM IST
- Ranbaxy set to launch India's first malaria drugDrug major Ranbaxy has successfully completed the phase II clinical trials for the first malaria drug being developed in the country.05 Jul, 2008, 01.45 AM IST
- Ranbaxy completes phase II trials for anti-malaria drugRanbaxy has succesfully completed the phase II clinical trials for the first malaria drugs being developed in India since many decades and ...04 Jul, 2008, 03.05 PM IST
- Ranbaxy first Indian pharma to launch NCE globallyRanbaxy has completed the second phase of the clinical trial of a revolutionary anti- malarial drug.05 Sep, 2007, 03.45 PM IST
- IPCA, CDRI to develop anti-malarial drugs based on ArtemisininIPCA Laboratories and Central Drug Research Institute (CDRI) will develop a synthetic substitute of anti-malarial drugs.27 Aug, 2007, 01.15 PM IST
Load More
